GC
PFE icon

Guidance Capital’s Pfizer PFE Stock Holding History

Guidance Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,886
Closed -$1.02M – 222
2024
Q3 		$1.02M Buy
34,886
+706
+2% +$20.6K 0.32% 69
2024
Q2 		$1.04M Buy
34,180
+3,455
+11% +$95.1K 0.34% 61
2024
Q1 		$796K Buy
30,725
+11,880
+63% +$330K 0.29% 72
2023
Q4 		$560K Buy
18,845
+3,765
+25% +$114K 0.22% 102
2023
Q3 		$511K Buy
15,080
+1,358
+10% +$48K 0.23% 90
2023
Q2 		$495K Buy
+13,722
New +$534K 0.22% 95

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guidance Capital's PFE Position: Q4 2024 in Review

Guidance Capital sold out of Pfizer (PFE) in Q4 2024, closing a stake of 34,886 shares — an estimated $1.02M sold.

Guidance Capital first reported a position in PFE in Q2 2023 and held it in 6 quarters. The position peaked at $1.04M in Q2 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Guidance Capital reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Guidance Capital sold 34,886 Pfizer shares in Q4 2024, an estimated $1.02M.
  • Guidance Capital first reported a position in Pfizer in Q2 2023 and held it in 6 quarters.
  • Guidance Capital's Pfizer position peaked at $1.04M in Q2 2024.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Guidance Capital's 13F filing for Q4 2024, filed 27 Jan 2025.